Stem definition | Drug id | CAS RN |
---|---|---|
Rho protein kinase inhibitors | 1132 | 103745-39-7 |
None
Property | Value | Reference |
---|---|---|
Vd (Volume of distribution) | 1.22 L/kg | Lombardo F, Berellini G, Obach RS |
CL (Clearance) | 77.50 mL/min/kg | Lombardo F, Berellini G, Obach RS |
t_half (Half-life) | 0.44 hours | Lombardo F, Berellini G, Obach RS |
Date | Agency | Company | Orphan |
---|---|---|---|
June 30, 1995 | PMDA |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | C04AX32 | CARDIOVASCULAR SYSTEM PERIPHERAL VASODILATORS PERIPHERAL VASODILATORS Other peripheral vasodilators |
MeSH PA | D002121 | Calcium Channel Blockers |
MeSH PA | D000077264 | Calcium-Regulating Hormones and Agents |
MeSH PA | D002317 | Cardiovascular Agents |
MeSH PA | D004791 | Enzyme Inhibitors |
MeSH PA | D049990 | Membrane Transport Modulators |
MeSH PA | D047428 | Protein Kinase Inhibitors |
MeSH PA | D014665 | Vasodilator Agents |
CHEBI has role | CHEBI:35620 | vasodilator agents |
CHEBI has role | CHEBI:35674 | antihypertensive drugs |
CHEBI has role | CHEBI:38215 | calcium channel blockers |
CHEBI has role | CHEBI:50925 | serine/threonine protein kinase inhibitor |
CHEBI has role | CHEBI:63726 | neuroprotective agents |
CHEBI has role | CHEBI:66980 | intelligence enhancer |
CHEBI has role | CHEBI:176497 | geroprotectors |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Spasm of cerebral arteries | indication | 73173006 | |
Cerebral ischemia | indication | 287731003 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 8.04 | Basic |
pKa2 | 5.74 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Rho-associated protein kinase 1 | Kinase | INHIBITOR | Ki | 7 | CHEMBL | SCIENTIFIC LITERATURE | |||
Rho-associated protein kinase 2 | Kinase | INHIBITOR | Kd | 7.11 | CHEMBL | SCIENTIFIC LITERATURE | |||
Ribosyldihydronicotinamide dehydrogenase [quinone] | Enzyme | Kd | 5.61 | CHEMBL | |||||
Myosin light chain kinase, smooth muscle | Kinase | Ki | 4.44 | CHEMBL | |||||
Protein kinase C delta type | Kinase | Kd | 5.32 | CHEMBL | |||||
Serine/threonine-protein kinase N1 | Kinase | IC50 | 5.77 | CHEMBL | |||||
BMP-2-inducible protein kinase | Kinase | Kd | 4.47 | CHEMBL | |||||
Dual specificity protein kinase CLK1 | Kinase | Kd | 6.82 | CHEMBL | |||||
Ribosomal protein S6 kinase alpha-5 | Kinase | IC50 | 5.30 | CHEMBL | |||||
C-C motif chemokine 2 | Cytokine | IC50 | 5.16 | CHEMBL | |||||
Cyclin-dependent kinase 9 | Kinase | Kd | 5.37 | CHEMBL | |||||
Serine/threonine-protein kinase N2 | Kinase | IC50 | 6.11 | CHEMBL | |||||
Protein kinase C epsilon type | Kinase | IC50 | 5.52 | CHEMBL | |||||
Serine/threonine-protein kinase LATS1 | Kinase | Kd | 5.38 | CHEMBL | |||||
cAMP-dependent protein kinase catalytic subunit alpha | Kinase | AC50 | 5.81 | CHEMBL | |||||
Citron Rho-interacting kinase | Kinase | Kd | 4.31 | CHEMBL | |||||
Serine/threonine-protein kinase D2 | Kinase | Kd | 5.19 | CHEMBL | |||||
Serine/threonine-protein kinase D3 | Kinase | Kd | 4.63 | CHEMBL | |||||
Cyclin-dependent kinase 13 | Kinase | Kd | 5.34 | CHEMBL | |||||
Serine/threonine-protein kinase N3 | Kinase | Kd | 7 | CHEMBL | |||||
Cyclin-dependent kinase 12 | Kinase | Kd | 5.46 | CHEMBL | |||||
Maternal embryonic leucine zipper kinase | Kinase | Kd | 5.72 | CHEMBL | |||||
Potassium voltage-gated channel subfamily H member 2 | Ion channel | Ki | 4.60 | CHEMBL | |||||
Rho-associated protein kinase 2 | Kinase | IC50 | 5.72 | CHEMBL |
ID | Source |
---|---|
D01840 | KEGG_DRUG |
105628-07-7 | SECONDARY_CAS_RN |
C0062068 | UMLSCUI |
CHEBI:43871 | CHEBI |
M77 | PDB_CHEM_ID |
CHEMBL541388 | ChEMBL_ID |
CHEMBL38380 | ChEMBL_ID |
DB08162 | DRUGBANK_ID |
C049347 | MESH_SUPPLEMENTAL_RECORD_UI |
3547 | PUBCHEM_CID |
5181 | IUPHAR_LIGAND_ID |
6696 | INN_ID |
Q0CH43PGXS | UNII |
None